Photo Credit: Andrey Popov

Women receive worse primary care-based chronic kidney disease (CKD) management than men, according to a research letter in the Journal of the American Medical Association. Researchers conducted a retrospective analysis of adult patients with CKD receiving primary care at 15 practices using electronic health record data to examine sex disparities in guideline-based CKD management and new care processes. The cohort included 7,903 adults (59.7% women). Across most outcomes, women experienced worse care than men, according to the findings. Women were less likely to have any laboratory testing (adjusted odds ratio, 0.83); however, no significant differences were seen in cystatin C testing (1.1% versus 1.6%). Women were less likely than men to be prescribed a renal-angiotensin-aldosterone system inhibitor or a sodium-glucose cotransporter-2 inhibitor (adjusted odds ratios, 0.80 and 0.41, respectively). Compared with men, women were less likely to have controlled blood pressure (adjusted odds ratio, 0.82). Women were also less likely to see a nephrologist than men (adjusted odds ratio, 0.59).